HomeVICO • STO
add
Vicore Pharma Holding AB
Previous close
kr 8.64
Day range
kr 8.31 - kr 8.86
Year range
kr 6.92 - kr 23.45
Market cap
1.95B SEK
Avg Volume
1.78M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 62.73M | -9.28% |
Net income | -56.33M | 18.61% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -61.89M | 9.39% |
Effective tax rate | 0.17% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 466.44M | 79.68% |
Total assets | 478.73M | 40.77% |
Total liabilities | 43.75M | 15.24% |
Total equity | 434.98M | — |
Shares outstanding | 111.73M | — |
Price to book | 2.22 | — |
Return on assets | -30.77% | — |
Return on capital | -33.95% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -56.33M | 18.61% |
Cash from operations | -49.56M | 28.23% |
Cash from investing | -24.81M | — |
Cash from financing | 5.00K | -100.00% |
Net change in cash | -72.51M | -195.46% |
Free cash flow | -28.07M | 34.71% |
About
Founded
2000
Website
Employees
28